FENTANYL OVERDOSE SYMPTOMS AND DURATION SECRETS

Coadministration of pexidartinib (a CYP3A4 inducer) with sensitive CYP3A substrates might lead to major therapeutic failures. If concomitant use is unavoidable, improve the CYP3A substrate dosage in accordance with approved product or service labeling.If coadministration of CYP3A4 inhibitors with fentanyl is important, keep track of patients for re